Trial · NCT03681184
Adverse events489
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 489
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Rhinitis | Infections and infestations | Lumasiran/Lumasiran | 2 | 26 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 2 | 13 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo/Lumasiran | 1 | 13 | |
| other | Upper respiratory tract infection | Infections and infestations | Lumasiran/Lumasiran | 3 | 26 | |
| other | Contusion | Injury, poisoning and procedural complications | Placebo | 1 | 13 | |
| other | Contusion | Injury, poisoning and procedural complications | Placebo/Lumasiran | 0 | 13 | |
| other | Contusion | Injury, poisoning and procedural complications | Lumasiran/Lumasiran | 0 | 26 | |
| other | Gastrostomy tube site complication | Injury, poisoning and procedural complications | Placebo | 1 | 13 | |
| other | Gastrostomy tube site complication | Injury, poisoning and procedural complications | Placebo/Lumasiran | 0 | 13 | |
| other | Gastrostomy tube site complication | Injury, poisoning and procedural complications | Lumasiran/Lumasiran | 0 | 26 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Placebo | 1 | 13 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Placebo/Lumasiran | 0 | 13 | |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Lumasiran/Lumasiran | 1 | 26 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo | 0 | 13 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo/Lumasiran | 1 | 13 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Lumasiran/Lumasiran | 0 | 26 | |
| other | Arrhythmia supraventricular | Cardiac disorders | Placebo | 0 | 13 | |
| other | Arrhythmia supraventricular | Cardiac disorders | Placebo/Lumasiran | 1 | 13 | |
| other | Arrhythmia supraventricular | Cardiac disorders | Lumasiran/Lumasiran | 0 | 26 | |
| other | Thalassaemia beta | Congenital, familial and genetic disorders | Placebo | 0 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03681184/events?page=2